ScienceDaily (Jan. 5, 2008) — Most people wouldn't consider anthrax toxin to be beneficial, but this bacterial poison may someday be an effective cancer therapy. Anthrax toxin has actually been shown to be fairly selective in targeting melanoma cells, although the risk of non-cancer toxicity prevents any clinical use.

To develop a better and safer treatment, Stephen Leppla and colleagues created a mutated antrax toxin that could only be turned on by matrix metalloproteinases (MMP), proteins that are overproduced only in cancer cells.

When they tested this mutated toxin in mice, the researchers observed that 100% of the animals tolerated a dose that would be lethal for the natural toxin. The MMP-toxin was also better at killing melanoma tumors than natural toxin, due to its higher specificity and longer half-life in the blood.

Even better, Leppla and colleagues saw that MMP-toxin was not limited to melanoma, and could also kill other tumors like colon and lung. This more widespread activity was due to the toxin's ability to inhibit angiogenesis, or the formation of new blood vessels.

These encouraging mouse results suggest that modified anthrax toxin could be clinically viable, and this potent killer might someday be put to good use.

enlarge

After binding to cell surface markers, the MMP-activated PA protein (PA-L1) is cleaved by surface associated MMPs, releasing the PA20 fragment. The remaining receptor-bound fragment rapidly oligomerizes to form a heptamer. Up to three molecules of anthrax lethal factor (LF) bind to the heptamer, which is then internalized. Once inside the cell, the complex encounters an acidic environment, which induces a conformational change and allows the LF to enter the cytosol. LF released into the cytosol shuts down multiple signaling pathways, leading to inhibition of tumor angiogenesis and human melanoma cell death. (Credit: Image created by Drs. Shihui Liu, Mahtab Moayeri, and Stephen H. Leppla)

Related Stories

Anthrax Research Might Provide More Time For Treatment (July 31, 2003) — Researchers at Rensselaer Polytechnic Institute in Troy, N.Y., have been awarded new federal grant money to develop experimental compounds that may someday extend the period during which a person ...  > read more

Newly Identified Antibody May Neutralize Inhalation Anthrax Toxin (Oct. 19, 2006) — A newly identified antibody capable of neutralizing the inhalation anthrax toxin in rabbits and monkeys may offer an alternative method of preventing and treating infection in humans say US ...  > read more

Defensins Neutralize Anthrax Toxin (Apr. 1, 2005) — Researchers at the Max Planck Institute for Infection Biology in Berlin, headed by Prof. Dr. Stefan H.E. Kaufmann, have developed a new therapeutic strategy against anthrax using defensins, well ...  > read more

New Chemical Effective Against Anthrax (Apr. 23, 2007) — Scientists have identified a chemical that could be used as a new drug against ...  > read more

Search ScienceDaily

Will Your Cancer Spread?